Vanguard Group’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.05M | Buy |
2,002,866
+903,581
| +82% | +$3.63M | ﹤0.01% | 3022 |
|
|
2025
Q1 | $3.81M | Sell |
1,099,285
-19,594
| -2% | -$68K | ﹤0.01% | 3272 |
|
|
2024
Q4 | $7.36M | Buy |
1,118,879
+254,168
| +29% | +$1.67M | ﹤0.01% | 3103 |
|
|
2024
Q3 | $7.82M | Buy |
864,711
+234,792
| +37% | +$2.12M | ﹤0.01% | 3077 |
|
|
2024
Q2 | $10.1M | Buy |
629,919
+148,164
| +31% | +$2.38M | ﹤0.01% | 2912 |
|
|
2024
Q1 | $7.55M | Buy |
481,755
+65,573
| +16% | +$1.03M | ﹤0.01% | 3115 |
|
|
2023
Q4 | $5.59M | Buy |
+416,182
| New | +$5.59M | ﹤0.01% | 3244 |
|